V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10441853 | 10033553 | 1.9 | 84 | Curative (C) | 2018-08-26 | 2018-09-14 | CAPECITABINE + OXALIPLATIN | N | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100841485 |
| 10441870 | 10033554 | 1.74 | 110.3 | Curative (C) | 2016-10-28 | 2016-10-28 | CHOP R | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101715713 |
| 10441901 | 10033555 | 1.83 | 60.1 | Neo-adjuvant (N) | 2018-05-26 | 2018-06-01 | Rituximab | 02 | N | RITUXIMAB | 101768815 |
| 10441918 | 10033556 | 1.77 | 79.2 | null | 2019-10-08 | 2019-10-15 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101826915 |
| 10441920 | 10033557 | 1.6 | 55 | Curative (C) | 2018-06-15 | 2018-06-26 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101266156 |
| 10441926 | 10033558 | 1.74 | 70.8 | Curative (C) | 2017-05-27 | 2017-05-27 | CAPECITABINE + OXALIPLATIN | 02 | Y | CAPECITABINE + OXALIPLATIN | 100082449 |
| 10441942 | 10033559 | 1.71 | 52 | Palliative (P) | 2019-06-07 | 2019-06-07 | Rituximab | 02 | N | RITUXIMAB | 101579906 |
| 10441944 | 10033560 | 1.63 | 59.7 | Adjuvant (A) | 2017-02-22 | 2019-11-11 | IBRUTINIB | 02 | N | IBRUTINIB | 101577697 |
| 10441950 | 10033561 | 1.7 | 71.6 | null | 2021-11-22 | 2021-11-29 | IBRUTINIB | 02 | null | IBRUTINIB | 100297603 |
| 10441951 | 10033562 | 1.67 | 56 | Palliative (P) | 2015-10-30 | 2015-11-21 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 100413887 |
| 10441957 | 10033563 | 1.52 | 82.8 | Adjuvant (A) | 2019-10-21 | 2019-11-03 | Capecitabine | 02 | N | CAPECITABINE | 101442342 |
| 10441972 | 10033564 | 1.69 | 81 | 03 | 2018-11-07 | 2018-11-25 | Capecitabine + Oxaliplatin 21day | 02 | N | PEMBROLIZUMAB | 100938056 |
| 10441976 | 10033565 | 1.67 | 67.8 | Palliative (P) | 2019-01-22 | 2019-01-23 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | N | RITUXIMAB | 101415090 |
| 10441980 | 10033566 | 1.7 | 83.25 | Neo-adjuvant (N) | 2020-10-31 | 2020-11-08 | IBRUTINIB | 02 | null | IBRUTINIB | 101626943 |
| 10441981 | 10033567 | 1.59 | 73 | Not known (9) | 2017-01-31 | 2017-02-13 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 101854961 |
| 10441993 | 10033568 | 1.51 | 105.3 | Palliative (P) | 2020-01-09 | 2020-01-20 | Rituximab | 02 | null | RITUXIMAB | 100760687 |
| 10441996 | 10033569 | null | 116 | Curative (C) | 2017-03-02 | 2017-03-02 | CHOP R | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100369216 |
| 10442008 | 10033570 | 1.54 | 102.9 | Adjuvant (A) | 2019-01-06 | 2019-01-06 | Rituximab | 02 | N | RITUXIMAB | 101033224 |
| 10442010 | 10033571 | 1.63 | 0 | Adjuvant (A) | 2021-03-28 | 2021-04-27 | IBRUTINIB | 02 | null | IBRUTINIB | 100209644 |
| 10442039 | 10033572 | 1.75 | 83 | Disease modification (D) | 2016-05-25 | 2016-06-16 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100554416 |
| 10442076 | 10033573 | 1.75 | 0 | Adjuvant (A) | 2014-04-19 | 2014-04-26 | Capecitabine + Oxaliplatin 21day | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100120180 |
| 10442098 | 10033574 | 1.58 | 92.9 | Adjuvant (A) | 2021-10-05 | 2021-10-19 | Capecitabine + Oxaliplatin 21day | null | null | CAPECITABINE + OXALIPLATIN | 101261179 |
| 10442151 | 10033575 | 1.52 | 0 | 03 | 2020-03-01 | 2020-03-16 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100057019 |
| 10442177 | 10033576 | 1.7 | 63.95 | Curative (C) | 2019-10-16 | 2019-10-30 | Capecitabine + Oxaliplatin 21day | 02 | N | DOCETAXEL | 101102435 |
| 10442182 | 10033577 | 1.72 | 57 | 03 | 2015-12-24 | 2016-01-08 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 100871869 |
| 10442191 | 10033578 | 1.76 | 63.95 | Curative (C) | 2013-07-06 | 2015-05-01 | IBRUTINIB | 02 | N | IBRUTINIB | 100366570 |
| 10442199 | 10033579 | 1.65 | 67.1 | Palliative (P) | 2017-11-29 | 2017-11-29 | Rituximab | 02 | N | RITUXIMAB | 101300524 |
| 10442237 | 10033580 | 1.88 | 63.5 | Curative (C) | 2013-10-30 | 2017-04-12 | IBRUTINIB | 02 | N | IBRUTINIB | 100212063 |
| 10442250 | 10033581 | 1.58 | 72 | Palliative (P) | 2016-04-16 | 2016-04-30 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101588131 |
| 10442260 | 10033582 | 1.84 | 73.7 | Disease modification (D) | 2019-05-20 | 2019-05-20 | Capecitabine + Oxaliplatin 21day | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101591253 |
| 10442266 | 10033583 | 1.73 | 81.9 | Palliative (P) | 2020-02-25 | 2020-03-03 | Rituximab | N | N | RITUXIMAB | 100483309 |
| 10442288 | 10033584 | null | 58.8 | 02 | 2017-02-25 | 2017-03-05 | CHOP R - 21 days | 02 | N | PEMBROLIZUMAB | 101505352 |
| 10442300 | 10033585 | 1.67 | 82.95 | Adjuvant (A) | 2016-12-27 | 2017-01-15 | Capecitabine | 02 | N | CAPECITABINE | 100871517 |
| 10442303 | 10033586 | 1.54 | 94.2 | null | 2020-06-17 | 2020-06-24 | Capecitabine + Oxaliplatin 21day | 02 | null | DOCETAXEL | 101327943 |
| 10442318 | 10033587 | 1.56 | 67 | Disease modification (D) | 2017-06-27 | 2017-07-10 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100394733 |
| 10442333 | 10033588 | 1.62 | 60.1 | 03 | 2017-01-03 | 2017-02-02 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE | 101395558 |
| 10442342 | 10033589 | 1.67 | 72.3 | Palliative (P) | 2019-12-24 | 2019-12-25 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100764862 |
| 10442347 | 10033590 | 1.82 | 89.2 | Neo-adjuvant (N) | 2016-11-30 | 2016-12-16 | Capecitabine | 02 | N | CAPECITABINE | 101388605 |
| 10442357 | 10033591 | 1.63 | 98 | Palliative (P) | 2014-05-27 | 2014-06-11 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 100665830 |
| 10442363 | 10033592 | 1.62 | 77 | Palliative (P) | 2018-08-21 | 2018-09-02 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE | 101233253 |
| 10442365 | 10033593 | 1.77 | 75 | null | 2021-11-09 | 2021-11-10 | CAPECITABINE + OXALIPLATIN | 02 | null | CAPECITABINE + OXALIPLATIN | 101528381 |
| 10442368 | 10033594 | 1.69 | 83.7 | Disease modification (D) | 2021-06-01 | 2021-06-11 | IBRUTINIB | 02 | N | IBRUTINIB | 100847568 |
| 10442388 | 10033595 | 1.77 | 65.2 | Adjuvant (A) | 2019-05-26 | 2019-06-02 | CHOP R | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100108481 |
| 10442391 | 10033596 | 1.75 | 61 | Palliative (P) | 2018-03-19 | 2018-03-31 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 101225260 |
| 10442410 | 10033597 | 1.65 | 85.9 | Palliative (P) | 2018-12-29 | 2019-01-12 | Docetaxel | 02 | N | DOCETAXEL | 101137265 |
| 10442416 | 10033598 | 1.75 | 67 | null | 2021-12-11 | 2022-01-14 | Rituximab (Maintenance) | 02 | null | RITUXIMAB | 100190836 |
| 10442435 | 10033599 | 1.81 | 73.8 | null | 2021-11-19 | 2021-12-12 | Capecitabine | 02 | null | CAPECITABINE | 100502768 |
| 10442456 | 10033600 | 1.74 | 72.3 | null | 2021-10-06 | 2021-12-08 | CAPECITABINE + OXALIPLATIN | 02 | null | CAPECITABINE + OXALIPLATIN | 100099246 |
| 10442461 | 10033601 | 1.57 | 66 | null | 2020-07-02 | 2020-07-02 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 101192735 |
| 10442479 | 10033602 | 1.81 | 85 | null | 2018-02-08 | 2018-02-15 | CHOP R | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100565869 |